Illumina Postpones Q4, FY 2011 Earnings Release to Mull Over Roche's Hostile Bid | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Illumina today postponed the release of its fourth-quarter and full-year 2011 financial results as its board reviews Roche's $5.7 million hostile bid for the San Diego-based next-generation sequencing and microarray firm.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.